October 11, 2013
Quest Diagnostics Inc. hit Myriad Genetics Inc. with a lawsuit in California federal court on Thursday, seeking a declaration that Quest does not directly or indirectly infringe a number of Myriad's patents, including those protecting genes associated with an increased risk of breast cancer.